Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2014
09/30/2014US8846708 Salt of a pyrimidin derivative
09/30/2014US8846707 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
09/30/2014US8846674 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/30/2014US8846012 Melanin production inhibitor
09/25/2014WO2014151616A1 Biaryl amide compounds as kinase inhibitors
09/25/2014WO2014151030A1 Cell proliferation inhibitors and conjugates thereof
09/25/2014WO2014147889A1 Method for producing halohydantoin compound
09/25/2014WO2014147124A1 Synthesis of hydantoin containing peptide products
09/25/2014WO2014147078A1 New family of discriminating molecules for neutron and gamma rays and ionic liquids
09/25/2014US20140288106 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
09/25/2014US20140287640 Functionalized Ionic Liquids and Their Applications
09/24/2014EP2780329A1 Method for preparing pentacyclic anion salt
09/24/2014EP2780328A1 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/23/2014US8841483 Compositions useful as inhibitors of voltage-gated sodium channels
09/23/2014US8841276 Fulvene and fulvalene analogs and their use in treating cancers
09/23/2014US8840912 Imidazole derivatives useful for controlling microbial growth
09/23/2014CA2500935C Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
09/18/2014WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
09/18/2014WO2014141947A1 Cinnamic acid amide derivative
09/18/2014US20140275569 Method for decarboxylation of amino acids via imine formation
09/18/2014US20140275568 Crystal of 5-hydroxy-1h-imidazole-4-carboxamide 3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate
09/18/2014US20140275555 Articles and methods comprising persistent carbenes and related compositions
09/18/2014US20140275037 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
09/18/2014US20140275006 Azole derivative
09/18/2014US20140271955 Compounds and methods for inducing chondrogenesis
09/17/2014EP2776411A1 Modulators of c3a receptors
09/17/2014EP2776403A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators
09/16/2014US8835650 Substituted imidazolium compounds for treating disease
09/16/2014US8835649 Method of synthesizing organic molecules using ionic liquids comprising a carbanion
09/16/2014US8835480 Inhibitors for steroid response elements and related methods
09/16/2014US8835479 Agent for fungal dermatitis
09/16/2014US8835477 Method for the synthesis of 2-thiohistidine and the like
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835471 Use of angiotensin II agonists
09/16/2014US8835436 Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
09/16/2014US8835426 Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
09/16/2014CA2610402C Process for the synthesis of 5-(methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)-benzeneamine
09/12/2014WO2014138053A1 Neprilysin inhibitors
09/11/2014US20140256779 Novel compounds as opioid receptor modulators
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256701 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/11/2014US20140256698 Cathepsin inhibitors
09/11/2014US20140256685 Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
09/11/2014US20140256684 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
09/10/2014EP2773613A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/10/2014EP2773378A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids)
09/09/2014US8829201 Electrolyte Formulations
09/09/2014US8829198 Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
09/09/2014US8829036 Heterocyclic aspartyl protease inhibitors
09/09/2014US8828204 Redox polymers
09/09/2014CA2617282C Novel imidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
09/04/2014US20140249319 Chemical crosslinkers and compositions thereof
09/04/2014US20140249181 Tropolone compounds for treating or preventing retroviral infection
09/04/2014US20140249163 Malignant and non-malignant disease treatment with ras antagonists
09/04/2014US20140249161 Stilbene analogs and methods of treating cancer
09/03/2014EP2771319A1 Amino acid derivatives functionalized on the n- terminal capable of forming drug incapsulating microspheres
09/02/2014US8822701 Method for preparing and using aminoethyl imidazolidinone and the thiocarbonyl thereof
09/02/2014US8822700 Hepatitis C virus inhibitors
09/02/2014US8822697 Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same
09/02/2014US8822520 Substituted bicyclic HCV inhibitors
09/02/2014US8822459 Compound containing basic group and use thereof
09/02/2014US8821716 Desulfurization of hydrocarbons by ionic liquids and preparation of ionic liquids
08/2014
08/28/2014WO2014130550A1 Substituted diaryl derivatives as sphingosine receptor modulators
08/28/2014US20140243362 Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor
08/28/2014US20140243324 Use of hematopoietic growth factor mimetics
08/28/2014US20140237735 Zwitterionic azo dyestuffs for colouring keratin-including fibres
08/26/2014US8816095 Na channels, disease, and related assays and compositions
08/26/2014US8815929 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
08/26/2014US8815924 Heterocyclic carbonyl compounds
08/26/2014US8815923 Therapeutic compounds
08/26/2014US8815910 Compounds and methods for inhibiting phosphate transport
08/26/2014US8815853 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
08/21/2014WO2014127042A1 Hydantoins that modulate bace-mediated app processing
08/21/2014WO2014124850A1 Substituted [1,2,4]triazole and imidazole compounds
08/21/2014US20140235640 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/21/2014US20140235636 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
08/21/2014US20140235585 Substituted diaryl derivatives as sphingosine receptor modulators
08/20/2014EP2767531A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
08/19/2014US8809550 Androgen receptor antagonists and uses thereof
08/19/2014US8809402 Oxazolone and pyrrolidinone-substituted biphenyls as P2X3 and P2X2/3 antagonists
08/19/2014US8809333 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
08/14/2014WO2014123485A1 Protein purification methods
08/14/2014WO2014123239A1 Organic light-emitting device and display apparatus
08/14/2014WO2014121884A1 Substituted carboxylic acid derivatives as aggrecanase inhibitors for the treatment of osteoarthritis
08/14/2014US20140228439 Ketone compounds and compositions for cholesterol management and related uses
08/14/2014US20140228419 Novel Isocyanate And Isothiocyanate Compounds For Cancer Treatment
08/14/2014US20140227345 Components for producing amphoteric liposomes
08/13/2014CN103987723A Hcv ns5a的抑制剂 Hcv ns5a inhibitors
08/13/2014CN103980204A 离子液体催化胺类与α,β-不饱和缺电子受体方法 Amines catalyzed by ionic liquid with α, β- unsaturated electron-deficient acceptor method
08/13/2014CN103980203A 一种肌肽的制备新方法 A new method for the preparation of carnosine
08/13/2014CN103980151A 作为阿片样物质受体的拮抗剂或反向激动剂的新型化合物 Novel compounds as opioid receptor antagonists or inverse agonists of substance
08/13/2014CN103980141A 恩泽特鲁的合成方法 Trudeau's grace synthesis method
08/13/2014CN102653571B 一种用于治理环境污染的化合物及制备方法及再生方法 Compound and preparation method and regeneration method for controlling environmental pollution
08/13/2014CN102603642B 含镍夹心多金属氧酸盐抗癌药物及其合成方法 Nickel sandwich POMs anticancer drugs and synthetic methods
08/13/2014CN102325740B 使用蒸馏助剂蒸馏离子液体 Ionic liquids distilled using a distillation aid
08/13/2014CN102241679B 合成4H-咪唑并[1,5-a][1,4]苯二氮*特别是咪达唑仑和其盐的方法 Synthesized 4H- imidazo [1,5-a] [1,4] benzodiazepine * especially midazolam and salts thereof
08/13/2014CN102149687B 作为雄激素受体调节剂的咪唑烷化合物 As androgen receptor modulators imidazolidine compounds
08/12/2014US8802710 Metronidazole esters for treating rosacea
08/12/2014US8802709 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
08/07/2014US20140221658 Inhibition of cell proliferation
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 345